Literature DB >> 36031763

Tacrolimus for prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis: a potential new target of old drug?

Seok Jeong1.   

Abstract

Entities:  

Year:  2022        PMID： 36031763      PMCID： PMC9539293          DOI： 10.5946/ce.2022.188

Source DB:  PubMed          Journal:  Clin Endosc        ISSN： 2234-2400


× No keyword cloud information.
  10 in total

1.  Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.

Authors:  G L Plosker; R H Foster
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

Review 2.  Emerging Therapies to Prevent Post-ERCP Pancreatitis.

Authors:  Nikhil R Thiruvengadam; Michael L Kochman
Journal:  Curr Gastroenterol Rep       Date:  2020-11-13

3.  Exposure to Radiocontrast Agents Induces Pancreatic Inflammation by Activation of Nuclear Factor-κB, Calcium Signaling, and Calcineurin.

Authors:  Shunqian Jin; Abrahim I Orabi; Tianming Le; Tanveer A Javed; Swati Sah; John F Eisses; Rita Bottino; Jeffery D Molkentin; Sohail Z Husain
Journal:  Gastroenterology       Date:  2015-05-14       Impact factor: 22.682

4.  Preventive effect of tacrolimus on patients with post-endoscopic retrograde cholangiopancreatography pancreatitis.

Authors:  Harshavardhan Rao B; Paul K Vincent; Priya Nair; Anoop K Koshy; Rama P Venu
Journal:  Clin Endosc       Date:  2022-08-02

5.  Variation in Tacrolimus Trough Concentrations in Liver Transplant Patients Undergoing Endoscopic Retrograde Cholangiopancreatography: A Retrospective, Observational Study.

Authors:  Rongrong Wang; Weili Wang; Kuifen Ma; Xin Duan; Fangfang Wang; Mingzhu Huang; Wei Zhang; Tingbo Liang
Journal:  Front Pharmacol       Date:  2020-08-19       Impact factor: 5.810

Review 6.  A risk-benefit assessment of tacrolimus in transplantation.

Authors:  M Winkler; U Christians
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606

7.  Papillary cannulation and sphincterotomy techniques at ERCP: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline.

Authors:  Pier Alberto Testoni; Alberto Mariani; Lars Aabakken; Marianna Arvanitakis; Erwan Bories; Guido Costamagna; Jacques Devière; Mario Dinis-Ribeiro; Jean-Marc Dumonceau; Marc Giovannini; Tibor Gyokeres; Michael Hafner; Jorma Halttunen; Cesare Hassan; Luis Lopes; Ioannis S Papanikolaou; Tony C Tham; Andrea Tringali; Jeanin van Hooft; Earl J Williams
Journal:  Endoscopy       Date:  2016-06-14       Impact factor: 10.093

8.  Tacrolimus and Indomethacin Are Safe and Effective at Reducing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography in Patients Who Have Undergone Liver Transplantation.

Authors:  Nikhil R Thiruvengadam; Kimberly A Forde; Vinay Chandrasekhara; Nuzhat A Ahmad; Gregory G Ginsberg; Vandana Khungar; Michael L Kochman
Journal:  Clin Gastroenterol Hepatol       Date:  2019-10-14       Impact factor: 11.382

9.  Targeted inhibition of pancreatic acinar cell calcineurin is a novel strategy to prevent post-ERCP pancreatitis.

Authors:  Abrahim I Orabi; Li Wen; Tanveer A Javed; Tianming Le; Ping Guo; Subramaniam Sanker; David Ricks; Kristy Boggs; John F Eisses; Carlos Castro; Xiangwei Xiao; Krishna Prasadan; Farzad Esni; George K Gittes; Sohail Z Husain
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-01

10.  Effect of calcineurin inhibitor on post-endoscopic retrograde cholangiopancreatography pancreatitis in patients with liver transplantation: a propensity-matched cohort study.

Authors:  Hyoung-Chul Oh; Jeffrey J Easler; Ihab I El Hajj; James Watkins; Evan L Fogel; Lee McHenry; Stuart Sherman; Hyun Kang; Glen A Lehman
Journal:  Korean J Intern Med       Date:  2020-02-19       Impact factor: 2.884
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.